ArticleAging2025

Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP).

Sudipta Bar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.